Table 6 Cost-effectiveness analysis of four screening strategies (standardized per 10,000 individuals).

From: Comparative performance and health economic analysis of prenatal screening for down syndrome in Fujian province, China

Project

Strategy 1

Strategy 2

Strategy 3

Strategy 4

Total screening

10,000

10,000

10,000

10,000

Number of true positives (effect)

6.48

7.35

6.48

4.8

total cost (CNY)

12,360,700

9,205,500

12,614,300

19,649,100

CER(CNY)

1,907,500

1,252,400

1,946,700

4,091,900

ICER (Strategy 1 vs. Strategy 2) ( CNY)

ā€“

āˆ’ 3,626,700

ā€“

ā€“

  1. Standardized outcomes were computed per 10,000 screened individuals using proportional scaling. CER and ICER were calculated as described in the Methods. True positives may appear as decimals and are used for theoretical comparison across strategies, not as actual clinical case counts.
Back to article page